Guest guest Posted February 20, 2011 Report Share Posted February 20, 2011 IF ANYBODY IS A MEMBER OF ALT.THYROID SUPPORT NEWSGROUP or any other Thyroid group throughout the world PLEASE will you post the following information to the owner of the group or as a message to the group members. THIS IS VITAL. We need to show as many counterexamples to T4-only therapy as we can. So far, we have 702. This is one way you can help every sufferer of the symptoms of hypothyroidism get the thyroid hormone replacement their body requires. Luv - Sheila ___________________________________ Please would you pass the following information to the readers of your web site so they can take up the opportunity of registering their thyroid status if they fit this particular category. The Charity, Thyroid Patient Advocacy www.tpa-uk.org.uk is in the process of creating a World Register of Counterexamples to levothyroxine-only (T4) therapy. This short survey is applicable only to those who continued to suffer symptoms on T4-only therapy, and who found those symptoms disappeared once they were started on a T3 hormone containing product , whether synthetic or natural thyroid extract. The objective of this Register of Counterexamples to T4-only therapy is to draw to the attention of those responsible authorities throughout the world, the dire need for an urgent re-examination of the existing protocol for the diagnosis and management of the symptoms of hypothyroidism. If you fit this category, please will you complete the 3 questions with either 'YES', 'NO' or N/A here http://www.tpa-uk.org.uk/register_of_counterexamples.php All responses will be collated online, and your email address (if you provide one) will be used ONLY to contact you at a later date should this be becomes necessary. Sheila Thyroid Patient Advocate Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.